Company / Profit Margin
Rani Therapeutics Holdings, Inc. Profit Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-2920.0%
FY2025
5-year range
-2920.0% / -306.6%
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin changed -852% YoY in FY2025, a notable deviation from the 2-year average annual change of -385%.
Based on SEC 10-K filings.
-2920.0% in FY2025.
Declined from -1803.3% to -2920.0% over the past 4 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -2613.4pp
- 5-Year Change
- -
- 10-Year Change
- -
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -2920.0% | - |
| FY2024 | - | - |
| FY2022 | -306.6% | +83.0% |
| FY2021 | -1803.3% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026